Stage II Breast Cancer Withdrawn Phase Trials for Vorinostat (DB02546)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01695057Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast CancerTreatment